Web1. nov 2024 · Phesgo is indicated for use in combination with docetaxel for the treatment of adult patients with HER2-positive metastatic breast cancer who have not received prior … WebPhesgo 1.200 mg/600 mg solución inyectable 2. COMPOSICIÓN CUALITATIVA Y CUANTITAVIA Phesgo 600 mg/600 mg solución inyectable Un vial de 10 ml de solución …
Medicinal forms Pertuzumab with trastuzumab Drugs BNF NICE
Web7. feb 2024 · The Product Monograph includes three sections: Part I: Health Professional Information; Part II: Scientific Information; and; Patient Medication Information; Search Regulatory Decision Summaries: The Regulatory Decision Summary explains Health Canada’s decision for the product seeking market authorization. longsight dental practice rodericks
Details for: PHESGO - Drug and Health Products Portal
Web1. nov 2024 · 2.1 What is a product monograph? A Product Monograph is a factual, scientific document on a drug product that, devoid of promotional material, describes the properties, claims, indications and conditions of use of the drug and contains any other information that may be required for optimal, safe and effective use of the drug. Web16. mar 2024 · The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. Last updated on emc: 16 Mar 2024. This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. View or print the patient leaflet as PDF. Web1. nov 2024 · Phesgo is indicated for use in combination with docetaxel for the treatment of adult patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease [see Dosage and Administration (2.2) and Clinical Studies (14.1)]. longsight depot manchester